NC762

· NextCure, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NC762, covering 2025-04-22 to 2025-04-22. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]